JTT-305, an orally active calcium-sensing receptor antagonist, stimulates transient parathyroid hormone release and bone formation in ovariectomized rats-Reference-Cited by-同舟云学术

JTT-305, an orally active calcium-sensing receptor antagonist, stimulates transient parathyroid hormone release and bone formation in ovariectomized rats

Published:2011-10 Issue:1-2 Volume:668 Page:331-336
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Kimura Shuichi,Nakagawa Takashi,Matsuo Yushi,Ishida Yuji,Okamoto Yoshihisa,Hayashi Mikio

Publisher

Elsevier BV

Subject

Pharmacology

Reference38 articles.

1. A novel calcium-sensing receptor antagonist transiently stimulates parathyroid hormone secretion in vivo;Arey;Endocrinology,2005

2. Daily treatment with human recombinant parathyroid hormone-(1–34), LY333334, for 1year increases bone mass in ovariectomized monkeys;Brommage;J. Clin. Endocrinol. Metab.,1999

3. Extracellular calcium sensing and extracellular calcium signaling;Brown;Physiol. Rev.,2001

4. Cloning and characterization of an extracellular Ca2+-sensing receptor from bovine parathyroid;Brown;Nature,1993

5. Physiological changes in extracellular calcium concentration directly control osteoblast function in the absence of calciotropic hormones;Dvorak;Proc. Natl. Acad. Sci. USA,2004

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vivo treatment with calcilytic of CaSR knock‐in mice ameliorates renal phenotype reversing downregulation of the vasopressin‐AQP2 pathway;The Journal of Physiology;2024-02-17

2. Parathyroid hormone and parathyroid hormone–related protein;Marcus and Feldman's Osteoporosis;2021

3. Tissue Engineering and Regenerative Medicine Therapies for Cell Senescence in Bone and Cartilage;Tissue Engineering Part B: Reviews;2020-02-01

4. Discovery and Development of Calcimimetic and Calcilytic Compounds;Progress in Medicinal Chemistry;2018

5. Investigational anabolic agents for the treatment of osteoporosis: an update on recent developments;Expert Opinion on Investigational Drugs;2017-08-29